Trial
NCT02723435
Midostaurin in Treating Older Patients With Mutated Acute Myeloid Leukemia Post-Transplant
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Stanford University
Collaborators
—
Condition
Acute Myeloid Leukemia With Gene Mutations
Intervention
Midostaurin
Why stopped
Logistical and administrative issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-04